Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Regulatory News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Purchase by Chairman

25 Apr 2018 10:57

RNS Number : 0858M
Redx Pharma plc
25 April 2018
 

REDX PHARMA PLC

("Redx" or "the Company")

 

Share Purchase by Chairman

 

 

Alderley Park, 25 April 2018 Redx (AIM: REDX), the drug discovery and development company focused on cancer and fibrosis, announces that it has been notified that Iain Ross, Executive Chairman, has today acquired 150,000 Redx ordinary shares at a price of 11 pence per share. Following this, Mr Ross will hold 600,000 ordinary shares in the Company, representing 0.47 per cent. of the issued share capital.

 

 

For further information, please contact:

Redx Pharma Plc

T: +44 1625 469 918

Iain Ross, Executive Chairman

 

 

 

Cantor Fitzgerald Europe (Nominated Advisor & Broker)

 T: +44 20 7894 7000

Phil Davies

 

 

 

WG Partners LLP (Joint Broker)

T: +44 20 3705 9330

Claes Spång/ Chris Lee/ David Wilson

 

 

 

FTI Consulting

T: +44 20 3727 1000

Simon Conway/Stephanie Cuthbert

 

 

About Redx Pharma Plc 

Redx is a UK biotechnology company whose shares are traded on AIM (AIM:REDX). Redx is focused on creating and developing first, or potentially best in class drugs, in specific areas of cancer and fibrosis that address significant unmet medical need. Redx has an in-house discovery team with proven world-class chemistry capabilities.

 

 

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Iain Ross

2

Reason for notification

 

 

 

a.

Position/Status

Executive Chairman

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Redx Pharma Plc

b.

LEI

213800HMS4EBXO589Y37

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary Shares of 1p each

ISIN: GB00BSNB6S51

b.

Nature of the transaction

Purchase

c.

Price(s) and volume(s)

150,000

 

11 pence

d.

Aggregated information

- Aggregated Volume

- Price

N/A - Single Transaction

e.

Date of the transaction

25/04/18

f.

Place of the transaction

London Stock Exchange

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUVVKRWVASURR
Date   Source Headline
5th Aug 20207:00 amRNSAppointment of NED and changes to Board committees
4th Aug 20207:37 amRNSOut licensing agreement with AstraZeneca
20th Jul 202011:35 amRNSResult of General Meeting
2nd Jul 20202:05 pmRNSSecond Price Monitoring Extn
2nd Jul 20202:00 pmRNSPrice Monitoring Extension
1st Jul 202012:30 pmRNSDirector/PDMR Shareholding
30th Jun 202011:30 amRNSHolding(s) in Company
30th Jun 20207:46 amRNSShare Option Scheme
30th Jun 20207:02 amRNSInterim Results
30th Jun 20207:00 amRNSProposed financing of $30m and notice of GM
15th Jun 202011:05 amRNSSecond Price Monitoring Extn
15th Jun 202011:00 amRNSPrice Monitoring Extension
20th May 20207:00 amRNSChange of Adviser
18th May 20207:00 amRNSAppointment of Non-Executive Director
6th May 20208:45 amRNSHolding(s) in Company
5th May 20209:45 amRNSHolding(s) in Company
4th May 20209:32 amRNSForm 8.3 - [REDX PHARMA PLC]
1st May 202011:45 amRNSForm 8.5 (EPT/RI)
1st May 20207:00 amRNSOffer Closed
29th Apr 202011:45 amRNSForm 8.5 (EPT/RI)
23rd Apr 202011:45 amRNSForm 8.5 (EPT/RI)
23rd Apr 202011:32 amRNSResult of AGM and operational update
21st Apr 202011:45 amRNSForm 8.5 (EPT/RI)
20th Apr 202011:45 amRNSForm 8.5 (EPT/RI)
17th Apr 202011:45 amRNSForm 8.5 (EPT/RI)
15th Apr 202011:45 amRNSForm 8.5 (EPT/RI)
14th Apr 202011:45 amRNSForm 8.5 (EPT/RI)
9th Apr 20206:10 pmRNSRedx Pharma
9th Apr 20204:47 pmRNSPUBLICATION OF OFFER DOCUMENT
9th Apr 20201:58 pmRNSOffer Update - Share Acquisitions
7th Apr 202011:45 amRNSForm 8.5 (EPT/RI)
6th Apr 202011:45 amRNSForm 8.5 (EPT/RI)
3rd Apr 20209:44 amRNSForm 8 (DD) - Redx Pharma PLC
3rd Apr 20209:27 amRNSForm 8.5 - RedX Pharma Plc
3rd Apr 20209:14 amRNSHolding(s) in Company
3rd Apr 20207:00 amRNSForm 8.3 - Redx Pharma plc
2nd Apr 20202:31 pmRNSOffer Update - Share Acquisitions
2nd Apr 202012:27 pmRNSForm 8.5 - RedX Pharma Plc
2nd Apr 202011:45 amRNSForm 8.5 (EPT/RI)
2nd Apr 202011:20 amRNSHolding(s) in Company
2nd Apr 20209:55 amRNSForm 8 (DD) - Redx Pharma PLC
1st Apr 202012:13 pmRNSForm 8.5 - Redx Pharma Plc
1st Apr 202011:01 amRNSForm 8 (DD) - Redx Pharma PLC
31st Mar 20207:00 amRNSInformation regarding Company AGM
30th Mar 202011:45 amRNSForm 8.5 (EPT/RI)
30th Mar 20207:00 amRNS£5 million short term loan agreement
27th Mar 202011:45 amRNSForm 8.5 (EPT/RI)
27th Mar 202011:43 amRNSForm 8 (OPD) - Redx Pharma Plc
26th Mar 20202:03 pmRNSForm 8.3 - Redx Pharma plc
26th Mar 20201:42 pmRNSForm 8.3 - Redx Pharma plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.